\-\ Texto\\:\\ \ \(0\)\
\-\ normal\ \(4026\)\
\-\ surgery\ \(977\)\
\-\ a\\ 1\\ cm\\ oval\\ mass\\ is\\ attached\\ to\\ the\\ septum\\ pellucidum\\ at\\ the\\ foramen\\ of\\ monro\\ that\\ demonstrates\\ hyperintensity\\ on\\ t1wi\\ and\\ isointensity\\ on\\ t2wi\\.\\ \\ this\\ mass\\ does\\ not\\ enhance\\.\ \(0\)\
\-\ colloid\\ \\(neuroepithelial\\)\\ cyst\\ of\\ the\\ third\\ ventricle\ \(0\)\
\-\ giant\\ cell\\ astrocytoma\ \(5\)\
\-\ metastasis\ \(206\)\
\-\ ependymoma\ \(74\)\
\-\ subependymoma\ \(6\)\
\-\ choroid\\ plexus\\ papilloma\ \(11\)\
\-\ cysticercosis\ \(25\)\
\-\ central\\ neurocytoma\ \(3\)\
\-\ 43\\ year\\ old\\ hispanic\\ woman\\ with\\ increased\\ frequency\\ of\\ headaches\\/migraines\\.\ \(1\)\
\-\ differential\\ diagnosis\\ for\\ this\\ case\\ included\\ a\\ subependymal\\ giant\\ cell\\ astrocytoma\\ \\(sgca\\)\\.\\ \\ however\\ in\\ those\\ cases\\,\\ other\\ stigmata\\ of\\ tuberous\\ sclerosis\\ are\\ usually\\ present\\ i\\.e\\.\\ cortical\\/subcortical\\ tubers\\ and\\ subependymal\\ nodules\\.\\ \\ \\ also\\,\\ the\\ sgca\\ is\\ usually\\ in\\ the\\ lateral\\ ventricle\\,\\ attached\\ to\\ the\\ caudate\\.\ \(0\)\
\-\ metastasis\\ was\\ also\\ considered\\ however\\,\\ the\\ patient\\ had\\ no\\ known\\ primary\\ cancer\\ and\\ no\\ constitutional\\ symptoms\\.\\ \\ metastatic\\ lesions\\ also\\ usually\\ enhance\\.\ \(0\)\
\-\ a\\ subependymoma\\ was\\ felt\\ to\\ be\\ unlikely\\ as\\ these\\ tumors\\ are\\ usually\\ in\\ the\\ 4th\\ or\\ lateral\\ ventricles\\.\ \(0\)\
\-\ lastly\\,\\ a\\ choroid\\ plexus\\ papilloma\\ can\\ rarely\\ present\\ as\\ a\\ third\\ ventricle\\ mass\\ but\\ these\\ tumors\\ usually\\ demonstrate\\ frond\\-like\\ papillae\\ that\\ enhance\\.\ \(0\)\
\-\ besides\\,\\ the\\ most\\ common\\ mass\\ of\\ the\\ 3rd\\ ventricle\\ is\\ the\\ colloid\\ cyst\\ \\-\\ in\\ areas\\ not\\ endemic\\ for\\ cysticercosis\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ sgca\\:\\ 0\\.08517409105281641\ \(0\)\
\-\ usually\\:\\ 0\\.0626794264219024\ \(0\)\
\-\ ventricle\\:\\ 0\\.06188193850393097\ \(0\)\
\-\ enhance\\:\\ 0\\.059904162273076496\ \(0\)\
\-\ subependymoma\\:\\ 0\\.0583857942195818\ \(0\)\
\-\ cysticercosis\\:\\ 0\\.05139140929951708\ \(0\)\
\-\ subependymal\\:\\ 0\\.04929416770301633\ \(0\)\
\-\ attached\\:\\ 0\\.04906134111771139\ \(0\)\
\-\ colloid\\:\\ 0\\.04861187236761581\ \(0\)\
\-\ headaches\\/migraines\\:\\ 0\\.042587045526408206\ \(0\)\
\-\ cortical\\/subcortical\\:\\ 0\\.042587045526408206\ \(0\)\
\-\ choroid\\:\\ 0\\.04213691910833807\ \(0\)\
\-\ papilloma\\:\\ 0\\.04148531253060345\ \(0\)\
\-\ plexus\\:\\ 0\\.040116708501009\ \(0\)\
\-\ giant\\:\\ 0\\.03975882181810707\ \(0\)\
\-\ isointensity\\:\\ 0\\.037279739784050185\ \(0\)\
\-\ papillae\\:\\ 0\\.037279739784050185\ \(0\)\
\-\ besides\\:\\ 0\\.033931202679895855\ \(0\)\
\-\ stigmata\\:\\ 0\\.03318651340536804\ \(0\)\
\-\ frond\\-like\\:\\ 0\\.03318651340536804\ \(0\)\
\-\ third\\:\\ 0\\.033105765160869535\ \(0\)\
\-\ astrocytoma\\:\\ 0\\.03206135457655358\ \(0\)\
\-\ endemic\\:\\ 0\\.031972434041692165\ \(0\)\
\-\ tumors\\:\\ 0\\.031011752248024164\ \(0\)\
\-\ tubers\\:\\ 0\\.031003010392116555\ \(0\)\
\-\ metastasis\\:\\ 0\\.030905771268598323\ \(0\)\
\-\ lastly\\:\\ 0\\.030582665575741533\ \(0\)\
\-\ monro\\:\\ 0\\.02890002454062938\ \(0\)\
\-\ neuroepithelial\\:\\ 0\\.02787920766301002\ \(0\)\
\-\ caudate\\:\\ 0\\.027654473287962233\ \(0\)\
\-\ constitutional\\:\\ 0\\.027234128471587207\ \(0\)\
\-\ pellucidum\\:\\ 0\\.02615614030098716\ \(0\)\
\-\ neurocytoma\\:\\ 0\\.02615614030098716\ \(0\)\
\-\ hispanic\\:\\ 0\\.02615614030098716\ \(0\)\
\-\ t1wi\\:\\ 0\\.025411451026459343\ \(0\)\
\-\ oval\\:\\ 0\\.02501416552773001\ \(0\)\
\-\ t2wi\\:\\ 0\\.02476637183503653\ \(0\)\
\-\ also\\:\\ 0\\.024414776719857267\ \(0\)\
\-\ however\\:\\ 0\\.02298906333910213\ \(0\)\
\-\ mass\\:\\ 0\\.022965430085943275\ \(0\)\
\-\ hyperintensity\\:\\ 0\\.022727751496585444\ \(0\)\
\-\ tuberous\\:\\ 0\\.022727751496585444\ \(0\)\
\-\ cell\\:\\ 0\\.02230184262397571\ \(0\)\
\-\ 43\\:\\ 0\\.022274520795050882\ \(0\)\
\-\ cyst\\:\\ 0\\.022187160734551716\ \(0\)\
\-\ i\\.e\\:\\ 0\\.022062913922305017\ \(0\)\
\-\ frequency\\:\\ 0\\.021794460535083708\ \(0\)\
\-\ these\\:\\ 0\\.021486422144520193\ \(0\)\
\-\ septum\\:\\ 0\\.021124962161720683\ \(0\)\
\-\ 4th\\:\\ 0\\.020795453707486224\ \(0\)\
\-\ 3rd\\:\\ 0\\.020437444180173556\ \(0\)\
\-\ rarely\\:\\ 0\\.01979236498875074\ \(0\)\
\-\ foramen\\:\\ 0\\.019706859785371993\ \(0\)\
\-\ unlikely\\:\\ 0\\.01966466809470168\ \(0\)\
\-\ felt\\:\\ 0\\.019418975257824912\ \(0\)\
\-\ ventricles\\:\\ 0\\.019418975257824912\ \(0\)\
\-\ included\\:\\ 0\\.01903536763654757\ \(0\)\
\-\ those\\:\\ 0\\.018783887627098036\ \(0\)\
\-\ present\\:\\ 0\\.01864742757421914\ \(0\)\
\-\ ependymoma\\:\\ 0\\.018478675541969865\ \(0\)\
\-\ lateral\\:\\ 0\\.017842203339367636\ \(0\)\
\-\ nodules\\:\\ 0\\.01711361770725967\ \(0\)\
\-\ considered\\:\\ 0\\.016664456081858195\ \(0\)\
\-\ sclerosis\\:\\ 0\\.014827609823315675\ \(0\)\
\-\ that\\:\\ 0\\.014260683367718099\ \(0\)\
\-\ does\\:\\ 0\\.014085125943884088\ \(0\)\
\-\ areas\\:\\ 0\\.013890566044666989\ \(0\)\
\-\ cases\\:\\ 0\\.013752709487831557\ \(0\)\
\-\ central\\:\\ 0\\.013582760178067435\ \(0\)\
\-\ cancer\\:\\ 0\\.01357084668775249\ \(0\)\
\-\ differential\\:\\ 0\\.013106086132139755\ \(0\)\
\-\ known\\:\\ 0\\.01306304871721652\ \(0\)\
\-\ as\\:\\ 0\\.012488671554532635\ \(0\)\
\-\ primary\\:\\ 0\\.012228909482587905\ \(0\)\
\-\ not\\:\\ 0\\.011930615185912418\ \(0\)\
\-\ are\\:\\ 0\\.011254820024440596\ \(0\)\
\-\ cm\\:\\ 0\\.01107225177689365\ \(0\)\
\-\ lesions\\:\\ 0\\.01105101693885965\ \(0\)\
\-\ common\\:\\ 0\\.01080322324616617\ \(0\)\
\-\ metastatic\\:\\ 0\\.01039183286771058\ \(0\)\
\-\ symptoms\\:\\ 0\\.010288200371488594\ \(0\)\
\-\ increased\\:\\ 0\\.010098960298549061\ \(0\)\
\-\ surgery\\:\\ 0\\.010024150069373308\ \(0\)\
\-\ 1\\:\\ 0\\.009822832695457522\ \(0\)\
\-\ a\\:\\ 0\\.00957970535793723\ \(0\)\
\-\ was\\:\\ 0\\.009548575093852046\ \(0\)\
\-\ woman\\:\\ 0\\.009535763031347374\ \(0\)\
\-\ most\\:\\ 0\\.009530604549410996\ \(0\)\
\-\ other\\:\\ 0\\.00951516207102632\ \(0\)\
\-\ demonstrate\\:\\ 0\\.009499768798710341\ \(0\)\
\-\ diagnosis\\:\\ 0\\.009479320438552753\ \(0\)\
\-\ can\\:\\ 0\\.009363393007096954\ \(0\)\
\-\ this\\:\\ 0\\.009286349887093072\ \(0\)\
\-\ case\\:\\ 0\\.009031422381001308\ \(0\)\
\-\ demonstrates\\:\\ 0\\.00901749372779317\ \(0\)\
\-\ had\\:\\ 0\\.00890748704947202\ \(0\)\
\-\ \\-\\:\\ 0\\.008848929752214317\ \(0\)\
\-\ but\\:\\ 0\\.008804363773108876\ \(0\)\
\-\ no\\:\\ 0\\.008313470055109198\ \(0\)\
\-\ is\\:\\ 0\\.008149141715720662\ \(0\)\
\-\ in\\:\\ 0\\.008142941645222317\ \(0\)\
\-\ \\,\\:\\ 0\\.007846668565718475\ \(0\)\
\-\ the\\:\\ 0\\.007346580346569487\ \(0\)\
\-\ for\\:\\ 0\\.007044523175291933\ \(0\)\
\-\ on\\:\\ 0\\.00699411606150172\ \(0\)\
\-\ \\(\\:\\ 0\\.006979340350182227\ \(0\)\
\-\ \\)\\:\\ 0\\.006894083981771063\ \(0\)\
\-\ normal\\:\\ 0\\.006471557751686478\ \(0\)\
\-\ be\\:\\ 0\\.00636597450890787\ \(0\)\
\-\ to\\:\\ 0\\.006189392875985308\ \(0\)\
\-\ at\\:\\ 0\\.00559305870933156\ \(0\)\
\-\ or\\:\\ 0\\.004838274149583128\ \(0\)\
\-\ year\\:\\ 0\\.0046188660351348535\ \(0\)\
\-\ old\\:\\ 0\\.004226737182909442\ \(0\)\
\-\ patient\\:\\ 0\\.004138125270127478\ \(0\)\
\-\ of\\:\\ 0\\.0028141014685504452\ \(0\)\
\-\ and\\:\\ 0\\.0026088261700321514\ \(0\)\
\-\ \\.\\:\\ 0\\.0020579441215852912\ \(0\)\
\-\ with\\:\\ 0\\.0005652375656516412\ \(0\)\
